Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder

Details for Australian Patent Application No. 2006331857 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Smith-Swintosky, Virginia L.; Reitz, Allen B.

Agent Shelston IP

Pub. Number AU-A-2006331857

PCT Pub. Number WO2007/075695

Priority 11/612,222 18.12.06 US; 60/751,493 19.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075695 Priority application(s): WO2007/075695

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331864-Method for producing frozen dough

2006331850-Substituted aniline derivatives useful as histamine H3 antagonists